Trial intelligence / Profile preview

P276-00 in Advanced Head and Neck Cancer

NCT00824343Phase 2Completed

Sponsor
Piramal Enterprises Limited
Start
Sep 2008
Primary completion
Apr 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of P276 in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Piramal Enterprises Limited. Started Sep 2008; status: completed.

02

Drugs

P276
03

Conditions

squamous cell carcinoma of the head and neck (HNSCC)

Beyond the preview

Go deeper on NCT00824343.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00824343.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call